BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21191740)

  • 21. CT perfusion assessment of Moyamoya syndrome before and after direct revascularization (superficial temporal artery to middle cerebral artery bypass).
    Chen Y; Xu W; Guo X; Shi Z; Sun Z; Gao L; Jin F; Wang J; Chen W; Yang Y
    Eur Radiol; 2016 Jan; 26(1):254-61. PubMed ID: 25925360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral Blood Flow Improvement after Indirect Revascularization for Pediatric Moyamoya Disease: A Statistical Analysis of Arterial Spin-Labeling MRI.
    Blauwblomme T; Lemaitre H; Naggara O; Calmon R; Kossorotoff M; Bourgeois M; Mathon B; Puget S; Zerah M; Brunelle F; Sainte-Rose C; Boddaert N
    AJNR Am J Neuroradiol; 2016 Apr; 37(4):706-12. PubMed ID: 26585258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
    Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
    Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease.
    Zaharchuk G; Do HM; Marks MP; Rosenberg J; Moseley ME; Steinberg GK
    Stroke; 2011 Sep; 42(9):2485-91. PubMed ID: 21799169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial spin labeling as an ancillary assessment to postoperative conventional angiogram in pediatric moyamoya disease.
    Lang SS; Tucker AM; Schreiber C; Storm PB; Liu H; Li Y; Ichord R; Beslow LA; Sedora-Roman NI; Cox M; Nasser H; Vossough A; Fisher MJ; Kilbaugh TJ; Huh JW
    J Neurosurg Pediatr; 2022 Jan; 29(1):40-47. PubMed ID: 34598159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.
    Goetti R; O'Gorman R; Khan N; Kellenberger CJ; Scheer I
    Neuroradiology; 2013 May; 55(5):639-47. PubMed ID: 23404242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult Moyamoya disease: 320-multidetector row CT for evaluation of revascularization in STA-MCA bypasses surgery.
    Tian B; Xu B; Liu Q; Hao Q; Lu J
    Eur J Radiol; 2013 Dec; 82(12):2342-7. PubMed ID: 24094737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Cerebral Hyperperfusion Syndrome Following Superficial Temporal Artery to Middle Cerebral Artery Bypass based on Intraoperative Perfusion-Weighted Magnetic Resonance Imaging.
    Wang D; Zhu F; Fung KM; Zhu W; Luo Y; Chu WCW; Tong Mok VC; Wu J; Shi L; Ahuja AT; Mao Y
    Sci Rep; 2015 Sep; 5():14140. PubMed ID: 26365751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superior Visualization of Neovascularization with Silent Magnetic Resonance Angiography Compared to Time-of-Flight Magnetic Resonance Angiography After Bypass Surgery in Moyamoya Disease.
    Suzuki T; Hasegawa H; Okamoto K; Shibuya K; Takahashi H; Fujiwara H; Oishi M; Fujii Y
    World Neurosurg; 2023 Jul; 175():e1292-e1299. PubMed ID: 37149090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?
    Mukerji N; Cook DJ; Steinberg GK
    J Neurosurg; 2015 Jan; 122(1):90-4. PubMed ID: 25343178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can 3T MR angiography replace DSA for the identification of arteries feeding intracranial meningiomas?
    Uetani H; Akter M; Hirai T; Shigematsu Y; Kitajima M; Kai Y; Yano S; Nakamura H; Makino K; Azuma M; Murakami R; Yamashita Y
    AJNR Am J Neuroradiol; 2013 Apr; 34(4):765-72. PubMed ID: 23079409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease.
    Lehman VT; Cogswell PM; Rinaldo L; Brinjikji W; Huston J; Klaas JP; Lanzino G
    Neurosurg Focus; 2019 Dec; 47(6):E6. PubMed ID: 31786551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis?
    Kaku Y; Morioka M; Ohmori Y; Kawano T; Kai Y; Fukuoka H; Hirai T; Yamashita Y; Kuratsu J
    Acta Neurochir (Wien); 2012 Dec; 154(12):2151-7. PubMed ID: 22935819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-up.
    Arias EJ; Dunn GP; Washington CW; Derdeyn CP; Chicoine MR; Grubb RL; Moran CJ; Cross DT; Dacey RG; Zipfel GJ
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1597-608. PubMed ID: 25972283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perfusion Quantification using Arterial Spin Labeling Magnetic Resonance Imaging after Revascularization for Moyamoya Disease.
    Liang L; Lei Y; Su J; Zhou P; Lv H; Wang T; Ma T
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():4326-4329. PubMed ID: 31946825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enlarged Encephalo-Duro-Myo-Synangiosis Treatment for Moyamoya Disease in Young Children.
    Shen W; Xu B; Li H; Gao X; Liao Y; Shi W; Zhao R; Zhang Y
    World Neurosurg; 2017 Oct; 106():9-16. PubMed ID: 28645592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the degree of arteriovenous shunting in intracranial arteriovenous malformations using pseudo-continuous arterial spin labeling magnetic resonance imaging.
    Sunwoo L; Sohn CH; Lee JY; Yi KS; Yun TJ; Choi SH; Cho YD; Kim JH; Park SW; Han MH; Paek SH; Kim YH; Kim JW; Chung HT; Kim DG
    Neuroradiology; 2015 Aug; 57(8):775-82. PubMed ID: 25903432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel magnetic resonance angiography stage grading for moyamoya disease.
    Houkin K; Nakayama N; Kuroda S; Nonaka T; Shonai T; Yoshimoto T
    Cerebrovasc Dis; 2005; 20(5):347-54. PubMed ID: 16131804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.